Exploring how SYK inhibition can restore paclitaxel sensitivity in resistant ovarian cancer cells through innovative research and clinical applications.
Discover how BRCA1's role extends beyond DNA repair to influence ovarian cancer cell migration through Profilin-1 (Pfn1) regulation.